Vident Advisory, LLC Maravai Lifesciences Holdings, Inc. Transaction History

Vident Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.21 - $6.13 $181,622 - $503,775	82,182 Added 289.53%	110,567 $244 Million
Q4 2024 Feb 14, 2025	SELL	$4.42 - $8.5 $433 - $833	-98 Reduced 0.34%	28,385 $155 Million
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $57,627 - $81,975	-8,425 Reduced 22.83%	28,483 $237 Million
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $83,601 - $137,996	12,169 Added 49.19%	36,908 $264 Million
Q1 2024 May 14, 2024	BUY	$5.11 - $8.76 $48,529 - $83,193	9,497 Added 62.31%	24,739 $214 Million

Q4 2023 Feb 14, 2024	SELL	$4.7 - $9.87 $89,032 - $186,967	-18,943 Reduced 55.41%	15,242 $99.8 Million
Q3 2023 Feb 21, 2024	BUY	$9.14 - $12.85 $173,139 - $243,417	18,943 Added 124.28%	34,185 $342 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $312,450 - $439,277	34,185 New	34,185 $342 Million

182

132M

688K

11.6K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.